Lazard Appoints David Krap as Managing Director

David has more than 20 years of experience advising companies on mergers and acquisitions (M&A), particularly in food and beverages, home and personal care, and consumer health.

He joins Lazard from J.P. Morgan, where he served as Managing Director and Co-Head of Consumer and Retail for EMEA. He previously held senior roles at Credit Suisse, Centerview Partners and UBS. He holds an honours degree from European Business School London and speaks German and Spanish.

Read More:Yoodli Appoints Mike Mather as Chief Learning Advisor

Based in London, David will join Lazard’s European financial advisory team, led by Jean-Louis Girodolle and Cyrus Kapadia. His appointment supports Lazard’s Lazard 2030 strategy, which focuses on strengthening its leadership team, and expanding its Managing Director ranks across the advisory business.

"David is a trusted counselor to many of the sector's leading businesses, and his deep expertise and longstanding relationships will further strengthen our franchise as we continue to invest in our European platform and enhance our capabilities for clients," said Cyrus Kapadia, Co-Head of European Investment Banking.

"I have long admired Lazard's advisory-led, partnership-oriented model and the strength of its presence and connectivity across Europe and North America. I am a firm believer in the ambitions of the Lazard 2030 strategy and the growth the firm is working to achieve. I look forward to joining Lazard's talented team, helping to shape and scale its global consumer franchise," said David Krap.

About Lazard

Founded in 1848, Lazard is a global financial advisory and asset management firm with offices across the Americas, Europe, the Middle East, Asia and Australia. The company advises businesses, governments and investors on mergers and acquisitions, capital markets, restructuring, and other financial matters. It also provides asset management, and investment services to institutions, companies, and individuals.

Read More:Sensorion Appoints Peter Weber as Chief Medical Officer